EN
Patient-first cell therapy innovation
 
2018
  • 0
Jia Q., Wu W., Wang Y., Alexander P.B., Sun C., Gong Z., Cheng J., Sun H., Guan Y., Xia X., Yang L., Yi X., Wan Y., Wang H., Futreal P.A., Li Q.-J.*, Zhu B.* (2018) Local mutational diversity drives intratumoral immune heterogeneity in non-small cell lung cancer. Nat Commun. 9(1):5361. (*: Corresponding authors, PMCID: PMC6299138)

Zhao L., He R., Long H., Guo B., Jia Q., Qin D., Liu S.-Q., Wang Z., Xiang T.,  Zhang J., Tan Y., Huang J., Chen J., Wang F., Xiao M., Gao J., Yang X., Zeng H., Wang X., Hu C., Alexander P. B., Symonds A.L.J.,  Yu J., Wan Y., Li Q.-J.*, Ye L.*, Zhu B.* (2018) Late-stage tumors induce anemia and immunosuppressive extramedullary erythroid progenitor cells. Nature Medicine 24(10):1536-1544 (*: Corresponding authors, PMCID: PMC6211844)
03.23
2022
Source:天科雅
Keysword:
Related Reading

Copyright © 2019 TCR CURE Biopharma Technology Co., Ltd Powered by vancheer
About TCRCure
Research and Development
Product and Cinical trial
News and Media
Recruitment

Copyright © 2019 TCR CURE Biopharma Technology Co., Ltd Powered by vancheer